Back
AGF U.S. Market Neutral Anti-Beta 10K Form
Sell
38
BTAL
AGF U.S. Market Neutral Anti-Beta
Last Price:
18.66
Seasonality Move:
-1.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BTAL News And Ratings
See the #1 stock for the next 7 days that we like better than BTAL
BTAL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
AGF U.S. Market Neutral Anti-Beta Earnings Forecast
Key AGF U.S. Market Neutral Anti-Beta Financial Ratios
AGF U.S. Market Neutral Anti-Beta Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | BTAL |
| CUSIP: | 351680 |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BTAL Technical Analysis vs Fundamental Analysis
Sell
38
AGF U.S. Market Neutral Anti-Beta (BTAL)
is a Sell
Is AGF U.S. Market Neutral Anti-Beta a Buy or a Sell?
-
AGF U.S. Market Neutral Anti-Beta stock is rated a Sell
The current AGF U.S. Market Neutral Anti-Beta [BTAL] share price is $18.73. The Score for BTAL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.